Eko, a digital health company advancing heart and lung disease detection, announced that the U.S. Food and Drug Administration (FDA) has cleared its Eko Murmur Analysis Software (EMAS) for detecting and characterizing murmurs found in adults and pediatric patients. The next generation of Eko's murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and differentiate, between innocent and structural, heart murmurs indicative of valvular heart disease.
Read more at AI Thority
Please note: Murmur detection is part of Eko’s SENSORA™ Cardiac Disease Detection Platform. Contact our sales team to learn more.